ArticleFrontiers in immunology2024

Comparing PD-L1 with PD-1 antibodies combined with lenvatinib and hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma.

Shaohua Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.